Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

While this option may be less expensive and seems convenient, it’s best to consult a doctor about dosage if you use it, says Joshua J. Neumiller, CDCES, PharmD, the president elect of ...

The global insulin delivery pen market is poised for remarkable growth, with its valuation projected to increase from USD 26,408.7 million in 2024 to USD 57,544.5 million by 2034, reflecting a robust ...

Polycystic ovary syndrome (PCOS) can put you at risk for insulin resistance. Watch for symptoms of insulin resistance that are common for females with PCOS. These include cravings and frequent ...

A single-center pilot study at the Veterans Affairs Hospital/University of Washington in Seattle reported improved verbal memory retention and attention after a three-week test of 20 international ...

The promise all good fountain pens deliver—be they expensive or affordable—is that they make your handwriting better than you ever imagined. At the very least, they make handwriting more fun ...

Novo Nordisk is applying for an expanded US label for its long-acting insulin Tresiba, hoping to gain an upper hand on Sanofi's older rival Lantus. Its data submitted to the FDA shows that ...

The list prices of its insulin drug Fiasp will be reduced by 75%, while the list prices of its Tresiba insulin will be reduced by 72.2%, Novo said in a statement. As a result, Novo will discontinue ...

There’s nothing quite like using the best fountain pens to get your writing done. The whole experience is rewarding, from purchasing one and unpacking it, to using it for the first time.

Medicare Part D covers diabetic medications, insulin and supplies to inject insulin such as syringes and insulin pens. Medicare Part D will pay for most of your insulin-related coverage including ...